We are live on ! Find out more
HC

Henshaw Capital Portfolio holdings

AUM $3.07B
1-Year Est. Return 40.85%
This Fund
S&P 500
This Quarter Est. Return
+3.84%
1 Year Est. Return
+40.85%
3 Year Est. Return
+128.2%
5 Year Est. Return
+170.36%
10 Year Est. Return
+567.65%
AUM
$1.1B
AUM Growth
+$29M
Cap. Flow
-$1.95M
Cap. Flow %
-0.18%
Top 10 Hldgs %
35.16%
Holding
315
New
21
Increased
127
Reduced
68
Closed
14

Top Buys

Rank Stock Value
1
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$4.97M
2
SPHQ icon
Invesco S&P 500 Quality ETF
SPHQ
+$3.02M
3
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
+$749K
4
SKM icon
SK Telecom
SKM
+$481K
5
WRB icon
W.R. Berkley
WRB
+$477K

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$8.87M
2
PIV
PWSHS S&P 500 HIGH QTY PORTF S&P HIGH QTY RKGS INDEX
PIV
+$2.98M
3
MORN icon
Morningstar
MORN
+$517K
4
MKL icon
Markel Group
MKL
+$438K
5
KEX icon
Kirby Corp
KEX
+$429K

Sector Composition

Rank Sector Weight
1 Technology 18.84%
2 Industrials 18.35%
3 Financials 12.7%
4 Communication Services 12.64%
5 Miscellaneous 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABEV icon
301
Ambev
ABEV
$44.1B
$155K 0.01%
33,475
-58,007
-63% -$341K
ADBE icon
302
Adobe
ADBE
$116B
– –
-1,052
Closed -$227K
AMKR icon
303
Amkor Technology
AMKR
$11.9B
– –
-19,940
Closed -$202K
EPAM icon
304
EPAM Systems
EPAM
$5.92B
– –
-1,846
Closed -$211K
EVTC icon
305
Evertec
EVTC
$1.79B
– –
-13,775
Closed -$225K
GMED icon
306
Globus Medical
GMED
$11.1B
– –
-4,662
Closed -$232K
GSK icon
307
GSK
GSK
$102B
– –
-181,592
Closed -$8.87M
TBHC
308
DELISTED
The Brand House Collective
TBHC
– –
-10,293
Closed -$99.7K
STNG icon
309
Scorpio Tankers
STNG
$3.91B
– –
-8,706
Closed -$171K
TEL icon
310
TE Connectivity
TEL
$58.7B
– –
-2,042
Closed -$204K
UGP icon
311
Ultrapar
UGP
$6.87B
– –
-22,286
Closed -$241K
TTM
312
DELISTED
Tata Motors Limited
TTM
– –
-16,654
Closed -$428K
LKSD
313
DELISTED
LSC Communications, Inc.
LKSD
– –
-18,108
Closed -$316K
CIVI
314
DELISTED
Civitas Solutions, Inc.
CIVI
– –
-11,950
Closed -$184K
PIV
315
DELISTED
PWSHS S&P 500 HIGH QTY PORTF S&P HIGH QTY RKGS INDEX
PIV
– –
-100,000
Closed -$2.98M
9 10 11 12
13

Similar funds

DMIC
Dixon Mitchell Investment Counsel Vancouver, British Columbia, Canada $3.07B AUM 16.75% 1-Year Est. Return
SAM
Smartleaf Asset Management Boston, Massachusetts $3.08B AUM 27.39% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
CI
Capital International Los Angeles, California $3.06B AUM 33.84% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return
SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $3.06B AUM 26.31% 1-Year Est. Return
WG
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return

Henshaw Capital's Q2 2018 Portfolio in Review

As of Q2 2018, Henshaw Capital held 315 positions worth $1.1B, up 2.7% from $1.07B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Henshaw Capital's Q2 2018 filing shows 21 new, 127 increased, 68 reduced and 14 closed positions. Its largest new stake was Invesco S&P 500 Quality ETF: 100,000 shares worth $3M. The largest sale was GSK, an estimated $8.87M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Industrials and Financials.

  • Henshaw Capital's largest Q2 2018 buy was Invesco S&P 500 Quality ETF: 100,000 shares worth $3M.
  • Henshaw Capital added most to Vanguard FTSE Emerging Markets ETF in Q2 2018, an estimated $4.97M increase.
  • Henshaw Capital's biggest Q2 2018 reduction was Morningstar, cutting an estimated $517K.
  • Henshaw Capital fully exited GSK in Q2 2018, selling an estimated $8.87M.
  • Henshaw Capital's ten largest holdings make up 35% of its $1.1B portfolio in Q2 2018.
  • Henshaw Capital opened 21 new positions and closed 14 in Q2 2018.
  • Henshaw Capital's portfolio value rose 2.7% quarter-over-quarter to $1.1B.

Based on Henshaw Capital's 13F filing for Q2 2018, filed 28 May 2026.